Ference, B. A., Cannon, C. P., Landmesser, U., Lüscher, T. F., Catapano, A. L., & Ray, K. K. (2018). Reduction of low density lipoprotein-cholesterol and cardiovascular events with proprotein convertase subtilisin-kexin type 9 (PCSK9) inhibitors and statins: An analysis of FOURIER, SPIRE, and the Cholesterol Treatment Trialists Collaboration. Eur Heart J.
Citação norma ChicagoFerence, Brian A., Christopher P. Cannon, Ulf Landmesser, Thomas F. Lüscher, Alberico L. Catapano, and Kausik K. Ray. "Reduction of Low Density Lipoprotein-cholesterol and Cardiovascular Events With Proprotein Convertase Subtilisin-kexin Type 9 (PCSK9) Inhibitors and Statins: An Analysis of FOURIER, SPIRE, and the Cholesterol Treatment Trialists Collaboration." Eur Heart J 2018.
ציטוט MLAFerence, Brian A., et al. "Reduction of Low Density Lipoprotein-cholesterol and Cardiovascular Events With Proprotein Convertase Subtilisin-kexin Type 9 (PCSK9) Inhibitors and Statins: An Analysis of FOURIER, SPIRE, and the Cholesterol Treatment Trialists Collaboration." Eur Heart J 2018.